Site- and Taxa-Specific Disease-Associated Oral Microbial Structures Distinguish Inflammatory Bowel Diseases. Issue 12 (14th May 2021)

• Record Type: Journal Article
• Authors: Somineni, Hari K; Weitzner, Jordan H; Venkateswaran, Suresh; Dodd, Anne; Prince, Jarod; Karikaran, Arjuna; Sauer, Cary G; Abramowicz, Shelly; Zwick, Michael E; Cutler, David J; Okou, David T; Chopra, Pankaj; Kugathasan, Subra
• Is Part Of: Inflammatory bowel diseases. Volume 27:Issue 12(2021)
• Page Start: 1889
• Page End: 1900
• Publication Date: 2021-05-14
• Subjects: IBD -- 16S rRNA -- microbiota -- microbiome -- spatial -- temporal -- longitudinal; Inflammatory bowel diseases -- Periodicals; Colitis, Ulcerative -- Periodicals; Crohn Disease -- Periodicals; Inflammatory Bowel Diseases -- Periodicals; 616.344
• DOI: 10.1093/ibd/izab082
• Languages: English
• ISSNs: 1078-0998

Abstract

Abstract: Background: The gut and oral microbiome have independently been shown to be associated with inflammatory bowel disease (IBD). However, it is not known to what extent gut and oral microbial disease markers converge in terms of their composition in IBD. Further, the spatial and temporal variation within the oral microenvironments of IBD remain to be elucidated. Patients and Methods: We used a prospectively recruited cohort of patients with IBD (n = 47) and unrelated healthy control patients (n = 18) to examine the spatial and temporal distribution of microbiota within the various oral microenvironments, represented by saliva, tongue, buccal mucosa, and plaque, and compared them with stool. Microbiome characterization was performed using 16S rRNA gene sequencing. Results: The oral microbiome displayed IBD-associated dysbiosis, in a site- and taxa-specific manner. Plaque samples depicted a relatively severe degree of dysbiosis, and the disease-associated dysbiotic bacterial groups were predominantly the members of the phylum Firmicutes. Our 16S rRNA gene analyses show that oral microbiota can distinguish patients with IBD from healthy control patients, with salivary microbiota performing the best, closely matched by stool and other oral sites. Longitudinal profiles of microbial composition suggest that some taxa are more consistently perturbed than others, preferentially in a site-dependent fashion. Conclusions: Collectively, these data indicate the potential of using oral microbial profiles in screening and monitoring patients with IBD. Furthermore, these results support the importance of spatial and longitudinal microbiome sampling to interpret disease-associated dysbiotic states and eventually to gain insights into disease pathogenesis.